Professor Jemma Hopewell
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Pharmacogenomics, cardio-omics, and cardiovascular drugs
Event: ESC Congress 2024
Topic: Pharmacogenetics
Session type: Moderated ePosters
Young Investigator Award Session in Population Science, Genetics and Epidemiology
Event: ESC Congress 2024
Topic: European Society of Cardiology
Session type: Award Sessions
Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation
Event: ESC Congress 2023
Topic: Heart Failure in Atrial Fibrillation
Session type: Moderated ePosters
Risk factors for cognitive impairment in atrial fibrillation patients
Event: ESC Congress 2023
Topic: Cognitive Function and Autonomy in Patients with Atrial Fibrillation
Session type: Moderated ePosters
Risks and screening for atrial fibrillation
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Atrial fibrillation and stroke: role of kidney disease and biomarkers
Event: ESC Congress 2023
Topic: Atrial Fibrillation (AF)
Session type: Abstract Sessions
Risk factors and prevention - Epidemiology 2
Event: ESC Congress 2022
Topic: Epidemiology
Session type: Moderated ePosters
Coronary artery disease - Epidemiology, prognosis, outcome 6
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Coronary artery disease - Epidemiology, prognosis, outcome 7
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Meet the trialist - Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease
Event: ESC Congress 2019
Topic: Epidemiology
Session type: Late-Breaking Science
